Biocryst Pharmaceuticals (BCRX) Interest & Investment Income: 2010-2015
Historic Interest & Investment Income for Biocryst Pharmaceuticals (BCRX) over the last 4 years, with Sep 2015 value amounting to $134,000.
- Biocryst Pharmaceuticals' Interest & Investment Income rose 857.14% to $134,000 in Q3 2015 from the same period last year, while for Sep 2015 it was $410,000, marking a year-over-year increase of 477.46%. This contributed to the annual value of $93,000 for FY2014, which is negligibly% changed negligibly from last year.
- As of Q3 2015, Biocryst Pharmaceuticals' Interest & Investment Income stood at $134,000, which was up 15.52% from $116,000 recorded in Q2 2015.
- In the past 5 years, Biocryst Pharmaceuticals' Interest & Investment Income ranged from a high of $134,000 in Q3 2015 and a low of $14,000 during Q3 2014.
- Over the past 3 years, Biocryst Pharmaceuticals' median Interest & Investment Income value was $21,000 (recorded in 2013), while the average stood at $50,273.
- In the last 5 years, Biocryst Pharmaceuticals' Interest & Investment Income slumped by 63.16% in 2013 and then spiked by 857.14% in 2015.
- Over the past 5 years, Biocryst Pharmaceuticals' Interest & Investment Income (Quarterly) stood at $84,000 in 2011, then crashed by 44.66% to $57,000 in 2012, then plummeted by 63.16% to $21,000 in 2013, then surged by 104.76% to $43,000 in 2014, then skyrocketed by 857.14% to $134,000 in 2015.
- Its Interest & Investment Income stands at $134,000 for Q3 2015, versus $116,000 for Q2 2015 and $117,000 for Q1 2015.